期刊文献+

胶原-聚羟基乙酸与骨髓间质干细胞的细胞相容性研究 被引量:7

A Study on the Biocompatibility between Collagen-Polyglicolic Acid and Bone Marrow Mesenchymal Stem Cells
原文传递
导出
摘要 目的 研究胶原 -聚羟基乙酸与骨髓间质干细胞的细胞相容性 ,为构建组织工程化肌腱提供实验基础。方法 分离、培养并鉴定骨髓间质干细胞 ,将骨髓间质干细胞置入含胶原 -聚羟基乙酸的DMEM培基中培养 ,设为实验组 ;将骨髓间质干细胞置入纯DMEM培基中培养 ,设为对照组。比较两组细胞的活性和生长情况 ,并对实验组进行超微结构观察。结果 骨髓间质干细胞接种于胶原 -聚羟基乙酸中后可适应材料生长 ,混合培养后 2周生长良好 ,始终保持 89%以上的细胞活力 ,与对照组比较无显著差别 (P >0 0 5 ) ;在 2周的培养过程中实验组细胞数未发生明显改变 ,而对照组从第 4d开始即发生增殖。透射电镜示实验组细胞培养 14d后仍保持旺盛的分泌功能。结论 骨髓间质干细胞与胶原 -聚羟基乙酸的细胞相容性好。以骨髓间质干细胞为种子细胞 ,以胶原 -聚羟基乙酸为支架可在体外预构组织工程化肌腱。 Objective To investigate the biocompatibility between collagen- polyglycolic acid (PGA) and bone marrow mesenchymal stem cells (MSCs) in vitro to provide some experimental basis for further study in tendon tissue engineering. Methods MSCs were isolated, cultured and characterized. In the experimental group the MSCs were cultured in DMEM containing type-I collagen and PGA suture, and in the control group the MSCs were cultured in DMEM. The cell growth was compared between the two groups, and the cell ultramicroscopic structure of experimental group was observed. Results MSCs grew well in the collagen-PGA scaffold, and 2 weeks after incubation they still kept secretion potential and more than cell 89% vitality, which were not significantly different compared with the control group. There is no statistical difference in the MSCs count in the experimental group during 2 weeks culture, while in the control group MSCs began to proliferate at the 4th day after culture. Conclusion Collagen-PGA has a good biocompatibility with mesenchymal stem cells. It is possible to fabricate a tissue-engineered tendon in vitro using mesenchymal stem cells as seed cells and collagen-PGA as scaffold.
出处 《中国医师杂志》 CAS 2005年第2期203-205,共3页 Journal of Chinese Physician
关键词 骨髓间质干细胞 聚羟基乙酸 胶原 对照组 细胞相容性 置入 组织工程化肌腱 培养过程 实验 结论 Marrow Mesenchymal stem cells Collagen Tissue engineering Tendon
  • 相关文献

参考文献6

二级参考文献28

  • 1侯春林,卢建照,包聚良,印木泉,曹梅讯.几丁质生物学特性研究[J].中国修复重建外科杂志,1993,7(2):115-116. 被引量:96
  • 2何尧祥 陈诗书 等.糖蛋白和糖脂.医学细胞与分子生物学[M].上海:上海医科大学出版社,1995.153-166.
  • 3Yang LJ, Jin L. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions[J]. Clin Orthop, 1990,257:249-256.
  • 4Kawamura M, Urist MR. Human fibrin is a physidogic delivery system for bone morphogenetic protein[J]. Clin Orthop, 1988,235:302 - 310.
  • 5Maysinger D, Krieglstein K, Filipovic GJ, et al. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities[J]. Exp Neurol, 1996,138(2) : 177 - 188.
  • 6Hiraki Y, Inoue H, Shigeno C. Bone morphogenetic protein(BMP-2 and BMP-3)promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cell in vitro[J].J Bone Mineral Res, 1991,6(12) : 1373 - 1385.
  • 7Groot KD. Carriers that concentrate native BMPs in vivo[J]. Tissue Engineering, 1998,4:337 - 340.
  • 8Lee EO, Kim JD. Palmitoyl lysozyme - induced stabilization of PE (phosphatidylethanolamine) liposomes and their interaction with Candida albicans[J]. J Biochem, 1995,117( 1 ) :.54 - 58.
  • 9Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ[J]. Biomaterials, 2000,21 (21):2155 - 2161.
  • 10Reddi AH. Role d mrphogenetic proteins in skeletal tissue engineering and regeneration[J]. Nature Biotechnology, 1998,16(3 ) :247 - 252.

共引文献26

同被引文献113

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部